Lipid accumulation in white adipose tissue is the key contributor to the obesity and orchestrates numerous metabolic health problems such as type 2 diabetes, hypertension, atherosclerosis, and cancer. Nonetheless, the prevention and treatment of obesity are still inadequate. Recently, scientists found that brown adipose tissue (BAT) in adult humans has functions that are diametrically opposite to those of white adipose tissue and that BAT holds promise for a new strategy to counteract obesity. In this study, we evaluated the potential of sinapic acid (SA) to promote the thermogenic program and lipolysis in BAT. SA treatment of brown adipocytes induced the expression of brown-adipocyte activation-related genes such as Ucp1, Pgc-1, and Prdm16. Furthermore, structural analysis and western blot revealed that SA upregulates protein kinase A (PKA) phosphorylation with competitive inhibition by a pan-PKA inhibitor, H89. SA binds to the adenosine triphosphate (ATP) site on the PKA catalytic subunit where H89 binds specifically. PKA-cat-1 gene-silencing experiments confirmed that SA activates the thermogenic program via a mechanism involving PKA and cyclic AMP response element-binding protein (CREB) signaling. Moreover, SA treatment promoted lipolysis via a PKA/p38-mediated pathway. Our findings may allow us to open a new avenue of strategies against obesity and need further investigation. [BMB Reports 2020; 53(3): 142-147] BMB Rep. 2020; 53(3): 142-147 www.bmbreports.org
INTRODUCTION
Brown adipose tissue (BAT) in adult humans was discovered recently in imaging studies and has a function opposite to that of white adipose tissue (1) . The unique feature of BAT is expression of UCP1, which helps to dissipate energy by diminishing the proton gradient in the inner membrane of mitochondria (2) . Cold exposure of adult human obese and normal subjects has various physiologically beneficial effects such as increased glucose uptake and increased insulin sensitivity (3) . In addition, cold exposure has been shown to cause BAT activation (4) .
Thus, the well-known method for activation of BAT is cold exposure, which increases norepinephrine secretion and thermogenesis. In a study on a mouse model, it has been demonstrated that differentiation of brown fat is accompanied by mitochondrial biogenesis (5) . Another study (on a brown preadipocyte cell line) has revealed that BMP7 treatment significantly increases the expression of genes involved in mitochondrial biogenesis and function, including Pgc-1 and Nrf1 (6) .
Certainly, PPAR is the central regulator of both white fat and brown fat cell development. C/EBP family members function cooperatively with PPAR and stimulate a transcriptional cascade to maintain a stable differentiated state of adipocytes. One report suggests that PPAR is necessary for brown-fat development but not sufficient to drive the full brown-fat program (which requires additional factors) (7) . Other studies offer evidence that transcriptional regulators including PPAR, PGC-1, PRDM16, and C/EBP can stimulate the development of brown fat (7, 8) . Recently, research revealed that phytochemicals such as rutin activate brown fat, and cryptotanshinone promotes brown-adipocyte commitment among mesenchymal stem cells (9, 10) .
In rodents, external stimuli lead to activation of -adrenergic receptor 3 (-3-AR) by sympathetic stimulation and increased cAMP production, which activates PKA and downstream genes of PKA (11) . The activation of PKA promotes the release of fuel (free fatty acids) for thermogenesis. In mice, PKA modulates http://bmbreports.org BMB Reports lipolysis activation involving 3-AR signaling which increases adenylyl cyclase activity and raises intercellular cAMP concentration (12) . The elevated cAMP level triggers PKA, which phosphorylates HSL, ATGL, and perilipin, and thus subsequently initiates lipolysis (13) . One report suggests that PKA upregulates UCP1 and plays role in both brownadipocyte differentiation and mitochondrial biogenesis (11) . Sinapic acid (SA) is a natural alkaloidal amine found in black mustard seeds, wine, and vinegar. SA has been reported to have several biological functions, including antioxidant, anti-inflammatory, anticancer, antimicrobial, antimutagenic, and antianxiety activities (14) . On the other hand, to date, the effects of SA on thermogenesis remain unexplored. In this study, we used BAT cells to find out the effect of SA on thermogenesis. We propose that SA holds promise as a potential secondary metabolite with a thermogenesis-promoting ability.
RESULTS

SA increases the expression of thermogenic markers and promotes mitochondrial biogenesis in brown adipocytes
During screening of 854 phytochemicals as described in our previous study (15) to find potential browning-thermogenic compounds, we found that SA can promote the activation of brown adipocytes. To decipher its function, at first, we tested the toxicity of SA toward brown adipocytes at indicated concentrations ( Fig. 1A ). It turned out that SA is not cytotoxic up to 72 h. Here, we compared the effects of SA with those of a well-known thermogenic inducer, Rosi, and BMP7 on the expression of thermogenic signature genes. SA treatment significantly enhanced Ucp1 mRNA expression, by 1.8-fold ( Fig. 1B) . Additionally, SA treatment increased the mRNA expression levels of Prdm16 (1.3-fold) and Pgc-1 (5.4-fold; Fig. 1B ). As shown in Fig. 1C , SA treatment raised the protein expression levels of PRDM16, PGC-1, PPAR, and UCP1. The quantification data revealed that SA treatment increased UCP1 protein expression 1.7-fold, PGC-1 1.9-fold, PRDM16 1.5-fold, and PPAR protein expression 1.8-fold (Fig. 1C ). It has been reported that PPAR and PGC1 activation can promote mitochondrial biogenesis. So, we tested some of the mitochondrial-biogenesis-related genes: Cox7a, Cox8b and Nrf1. As shown in Fig. 2A , SA increased mitochondrial biogenesis related markers. Then, we performed immunostaining with MitoTracker and quantify the stain. As shown in Fig. 2B , SA treated cells showed higher mitochondrial mass than MDI. Next, we measured mtDNA expression and found that SA significantly increased mtDNA ( Fig. 2C ). After that, we needed to test whether mitochondrial biogenesis leads to increased http://bmbreports.org oxygen consumption. As shown in Fig. 2D , SA treatment increased oxygen consumption. These data enabled us to propose that SA can induce the expression of thermogenic and mitochondrial biogenesis markers.
SA activates the PKA pathway in brown adipocytes
Of note, we found that SA and H89 share the ATP-binding pockets on the PKA surface via both hydrogen and hydrophobic interactions (Fig. 3A) , and Asp 184 in the active site of PKA (Fig. 3A) . Structural analysis revealed that the binding-affinity values of SA and H89 are −6.2 and −8.3 kcal/mol, respectively, implying that H89 binds more strongly than SA, but SA has the ability to slightly inhibit the activity of H89, as confirmed by western blotting (Fig. 3B) . We increased the SA concentration and treated PKA with H89; we found that SA treatment inhibited the H89 activity (Fig. 3B ). The molecular docking analysis suggests that SA may be a potent agonist for induction of PKA phosphorylation.
On the basis of this finding, we investigated PKA signaling during SA treatment. We found that SA treatment increases PKA substrate phosphorylation at 60 min as compared to the MDI medium ( Fig. 3C ). We also tested the phosphorylation of other downstream kinases of PKA signaling, where we found that SA stimulates phosphorylation of CREB, p38, and ERK as well (Fig. 3D ). We also observed that SA treatment promoted phosphorylation of HSL (Ser 563 and Ser 660 ) on day 6 during brown-adipocyte differentiation (Fig. 3E ). In addition, we assessed triglyceride (TG) accumulation by ORO staining (Supplemental Fig. 1A and B) .
To understand the function of SA in thermogenic gene induction, we confirmed the expression of PKA downstream genes, Ucp1, Pgc1 and Prdm16 in SA treated condition along with an activator of cAMP-dependent protein kinase, 8-bromoadenosine 3'.5'-cyclicmomophosphate (8-Br-cAMP) ( Fig. 4A and 4B ). Data suggested SA can effectively induce thermogenic genes. To confirm PKA signaling in SA-treated brown adipocytes, we tried to assess the effect of PKA inhibition on SA-mediated PKA substrate phosphorylation ( Fig.  4C and 4D ). The expression of downstream thermogenic target genes of PKA, e.g., Ucp1, Pgc1, Ppar, and Cebp was diminished by H89 treatment, but this effect was reversed by cotreatment with SA ( Fig. 4C ). As depicted in Fig. 4D ) phosphorylation was dramatically inhibited during H89 treatment. By contrast, during cotreatment with SA, the phosphorylation was significantly recovered.
We next studied the activities of the PKA signaling pathway during PKA-cat-1 gene silencing and SA treatment (Fig. 4E ). As illustrated in Fig. 4E , PKA-cat-l siRNA inhibited the mRNA expression of PKA-cat-l effectively. As expected, the expression of the downstream genes in the PKA signaling pathway was reduced by PKA-cat-l gene silencing, but this http://bmbreports.org BMB Reports effect was attenuated by SA treatment (Fig. 4F and 4G ).
Overall, we can propose that SA contributes to brownadipocyte activation and lipolysis via activation of PKA signaling (Fig. 4H ).
DISCUSSION
Stimulation of brown adipocytes and UCP1 mediated heat production require activation of adipocytes and muscle cell surface receptors, such as Trpv1, 3-AR, Ptch1, A2aR and TrkB. These receptors require cellular signaling cascades such as PKA, PKG, Sirt1, AMPK, and p38 MAPK, cytokines (IL-4 and IL-13), and transcriptional regulators, such as Prdm family, Pgc-1, Ppar family, and Zfp516 for UCP1 expression (16) . Several plant-extracted compounds (berberine, butein, capsaicin, and fucoxanthin), artificially synthesized compounds (e.g., a Ppar agonist, 3-AR agonist, and salsalate), and endogenous small-molecule factors (e.g., serotonin, lactate, and adenosine) have been identified as potential BAT activators that turn on thermogenic transcriptional factors by involving their cell surface receptors or by cellular signaling cascades modulation (16) . Our data revealed that SA acts as a potent stimulator of brown-adipocyte activation. The protein factors that control brown-fat differentiation were upregulated by SA treatment, including PPAR, PGC-1, CEBP, and PRDM16 along with increased expression of UCP1. mRNA and protein expression levels of a key thermogenic marker, UCP1, were increased by SA treatment here, indicating activation of mature BAT adipocytes. HSL activity appears to be regulated by site-specific phosphorylation on at least five serine residues ( (17, 18) . SA increases the phosphorylation of HSL (Ser 563 and Ser 660 ); during browning and during thermogenic activation of BAT, similar changes with increased lipolysis have been observed (19) .
The differentiation and physiological functions of brown adipocytes are closely related to enhance mitochondrial biogenesis. Researcher has demonstrated that PPAR and transcriptional coactivator PGC-1 can contribute to mitochondrial function and biogenesis (20) which are similar to our findings although further investigation is needed for molecular mechanism.
Computational identification of PKA agonist has been described elsewhere (21) where, lead compound share same binding site as SA, but described as an agonist of PKA. H89 inhibits the activation of CREB and the CREB-mediated MKP-1 induction by lipopolysaccharide (LPS) resulting from the inhibition of PKA and MSK by H89 (22) . Protein kinases catalyzes the transfer of -phosphate of ATP to the hydroxyl group present in a tyrosine, serine, or threonine residue to phosphorylate their substrates. The direct effects of H89 on active site of the enzyme causes its inhibitory actions. It also looked likely that H89 obstructs protein kinase activity via interacting with the free enzyme, not with the enzyme-ATP complex (23) . PKA mediates forskolin-induced CREB phosphorylation through p38 and MSK1 in NIH 3T3 cells (24) . In our study, H89 treatment inhibited PKA phosphorylation resulting lower effect of SA on HSL phosphorylation at PKA target sites, Ser 563 and Ser 660 ; our data are in agreement with the findings of other researchers (25) . SA and H89 both can bind competitively to PKA by sharing the ATP-binding site on a PKA catalytic subunit, as we showed by our molecular docking analysis and confirmed by western blotting. Our data indicate that the expression of target genes of PKA, e.g., Ucp1, Pgc1, Ppar, and Cebp, was reduced by H89 treatment, but this suppression was reversed by SA treatment. Besides, SA promoted phosphorylation of CREB, p38, and ERK; CREB phosphorylation was inhibited by H89 treatment, and this change was attenuated by SA treatment. In this context, we propose that SA-mediated PKA activation can induce both phosphorylation of its downstream targets and expression of browning-related genes although a fine-tuned study is needed to confirm this crosstalk.
In conclusion, this study revealed that SA not only activates the thermogenic program but also induces lipolysis. SAmediated thermogenic-signature upregulation is probably involved in the activation of UCP1 via PKA/CREB signaling.
Our findings may open up a new avenue of research on the downstream thermogenic program in in vivo models. 
MATERIALS AND METHODS
Chemicals, reagents, and antibodies
Cell maintenance and differentiation
BAT cells were cultured and maintained in the DMEM GlutaMax medium supplemented with 10% of FBS and 1% of the penicillin-streptomycin solution and were kept at 37 o C in a 5% CO2 incubator. BAT cells are an immortalized cell line created by Lee BS group (26) . The cells were differentiated as described elsewhere (27) . Cells after 6 days of differentiation were used in all the experiments unless stated otherwise.
Cell treatment procedures
Fully confluent BAT cells were treated with the MDI differentiation induction medium consisting of 0.5 mM 3-isobutyl-1-methylxanthine, 1 M dexamethasone, and 10 g/ml insulin in DMEM supplemented with 10% of FBS, followed by a maturation medium composed of DMEM, 10% of FBS, and 10 g/ml insulin. The media were refreshed every other day. The following treatment groups were set up: MDI, Rosi with MDI (positive control), BMP7 with MDI (positive control), and SA with MDI. Treatments exceeding 2 days were continued until day 4 by mixing drugs with the maturation medium. After day 4, only the maturation medium was used until cell harvesting. Preadipocytes were maintained only in the culture medium (DMEM and 10% of FBS).
Cell viability assay
In 96-well plates, BAT cells were seeded at 80% to 90% confluence. Cell viability was evaluated by MTT assay as described elsewhere (15) .
Analysis of mitochondrial DNA content
Mitochondrial biogenesis was quantified by real-time qPCR as described elsewhere (28) assuming that the ratio of mitochondrial DNA (mtDNA) to nuclear DNA (nDNA) increases but nDNA remains constant.
Oxygen consumption assay
BAT cells were seeded in a 96-well plate at a density of approximately 40,000-60,000 cells per well. Oxygen consumption assay was performed as kit protocol (Cayman, Ann Arbor, MI, USA).
Quantitative reverse-transcription PCR (qRT-PCR) analyses
Total-RNA extraction from (and qRT-PCR analyses of) BAT cells were performed as described previously (29) . The primer sequences employed in this study are listed in Supplemental  Table 1 . Expression of target genes was normalized to that of TATA box-binding protein (Tbp).
Preparation of whole-cell extracts for western blot (WB) analyses
Whole-cell extracts from BAT cells were prepared as described elsewhere (30) with a minor modification. Briefly, cell extracts were collected after 6 days of differentiation. Next, 1% BSA was used for blocking the membranes instead of skim milk (because of analysis of phosphoproteins), and a phosphatase inhibitor cocktail (Sigma-Aldrich) was added into RIPA lysis buffer (Santa Cruz Biotechnology, Inc.).
Gene silencing experiments
Gene silencing assay was conducted as described previously (31) .
In silico analysis
Western blot analysis revealed that SA upregulates phosphorylation of PKA in the absence of inhibitor H89 and attenuates H89-mediated dephosphorylation. To understand the mechanism better, molecular-docking-based structural analysis was performed. First, crystal structure of cAMP-dependent protein kinase (PDB ID: 1BX6) with a potent inhibitor, balanol (a natural product), bound to its catalytic subunit was obtained from Protein Data Bank (www.rcsb.org). After that, the ligand was removed, and a binding grid of (40 × 40 × 40, 1 Å) size was generated containing all possible active sites on PKA surface. Before docking, all the structures were prepared with AutoDock Tools (32), polar hydrogen was added, and finally molecular docking was performed in the AutoDock Vina software (33) .
Statistics
Data are representative of three or more experiments and are shown as mean ± standard error of the mean (SEM). Student's t test was conducted to identify significant changes between a control group and various treatment groups. Data with a P value of ＜ 0.05 were considered statistically significant.
